Advisor Group Holdings, Inc. Summit Therapeutics Inc. Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 12,161 shares of SMMT stock, worth $244,557. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,161
Previous 12,039
1.01%
Holding current value
$244,557
Previous $263,000
17.49%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SMMT
# of Institutions
211Shares Held
76.5MCall Options Held
2MPut Options Held
2.83M-
Baker Bros. Advisors LP New York, NY24.4MShares$491 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$220 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$159 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$109 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$69.8 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.05B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...